Meningitis B Vaccine Cost UK 2026: Complete Pricing Guide for Adults, Students and Children
Medically reviewed by The Wellness Medical Team — Last updated: 18 March 2026
The meningitis B vaccine (Bexsero) costs between £100 and £195 per dose privately in the UK, with a full two-dose course ranging from approximately £200 to £390 depending on the provider. High-street pharmacies typically charge £100–120 per dose, while doctor-led private clinics charge £150–195 per dose for a more comprehensive medical service. At The Wellness London, private MenB vaccination starts from £195 per dose, administered by GMC-registered doctors at our Marylebone clinic. Following the March 2026 Kent meningitis outbreak, vaccine supply is severely limited nationally, and many providers have suspended bookings entirely.
Check Availability & Book — WhatsApp →
What Does the Meningitis B Vaccine Cost at Different Providers
Understanding the range of pricing across different types of provider helps you make an informed decision about where to get vaccinated. Pricing varies depending on the type of service, the qualifications of the person administering the vaccine, and the level of medical consultation included.
High-street pharmacies such as Boots, Superdrug, and Well Pharmacy have historically been the most affordable option, charging between £100 and £120 per dose (£200–240 for the full two-dose course). These services are convenient and widely accessible, with vaccination typically administered by a qualified pharmacist. Boots, for example, has priced its full MenB course at £220. However, following the March 2026 Kent outbreak, almost all major pharmacy chains have either exhausted their stock or implemented waiting lists, and the National Pharmacy Association has confirmed there is "no stock" available across most wholesale distributors.
Travel clinics generally charge slightly more, in the range of £120–150 per dose, and may include a broader travel health consultation if you are preparing for international travel.
Private GP clinics and doctor-led healthcare providers typically charge the highest prices, ranging from £150 to £400 per dose. At The Wellness, the meningitis B vaccine starts from £195 per dose (£390 for the full two-dose course). This higher price reflects the quality and depth of the service — every vaccination at our clinic is prescribed by a GMC-registered doctor who conducts a comprehensive medical history review, assesses contraindications, discusses your individual risk profile, and monitors you after the injection. This level of clinical oversight is not available at pharmacy-based services.
Important context on current pricing: During periods of shortage, some providers may adjust their prices. The Health Secretary has publicly urged consumers not to be overcharged, and reputable clinics maintain transparent, published pricing regardless of demand. Our pricing at The Wellness London is clearly stated and does not change based on availability.
Who Is Eligible for a Free NHS Meningitis B Vaccine
Before paying for a private vaccine, it is worth understanding whether you or your child may be eligible for a free vaccination through the NHS.
The NHS currently provides the MenB vaccine free of charge to the following groups. Infants receive Bexsero as part of the routine childhood immunisation schedule, with doses at 8 weeks, 16 weeks, and a booster at 12 months. This programme began in September 2015, which means only children born on or after 1 May 2015 are covered.
Individuals with certain medical conditions that place them at higher risk of meningococcal disease are also eligible for free NHS vaccination regardless of age. These conditions include asplenia or hyposplenia (absent or non-functioning spleen), sickle cell disease, coeliac disease, complement disorders (including those on complement inhibitor treatment such as eculizumab), and certain other immunodeficiency conditions.
Following the 2026 Kent outbreak, a targeted NHS vaccination programme has begun for approximately 5,000 students living in halls of residence at the University of Kent's Canterbury campus. The Health Secretary has asked the Joint Committee on Vaccination and Immunisation (JCVI) to re-examine eligibility for meningitis vaccines, but as of 18 March 2026, no broader expansion of NHS eligibility has been announced.
Everyone else — including adults, teenagers born before 2015, university students not at the University of Kent, and children whose parents missed the routine schedule — must currently access the vaccine privately.
Enquire About Private Vaccination — WhatsApp →
Why Does the Meningitis B Vaccine Cost So Much
The price of the Bexsero vaccine reflects several factors that make it one of the more expensive routine vaccinations available in the UK.
The vaccine itself is technologically complex to manufacture. Unlike simpler polysaccharide vaccines, Bexsero is a recombinant protein vaccine that combines four separately produced antigens — three recombinant proteins and one outer membrane vesicle component — adsorbed onto an aluminium hydroxide adjuvant. This was a significant scientific achievement, as the MenB outer coating closely mimics human tissue, which meant traditional vaccine approaches were ineffective.
Bexsero is manufactured exclusively by GSK (previously Novartis Vaccines), with no generic or biosimilar alternatives available. This sole-supplier status means there is no competitive downward pressure on wholesale prices. The wholesale cost to providers is estimated at approximately £75–90 per dose, with the remainder of the retail price covering clinical assessment, administration, consumables, cold-chain storage, post-vaccination monitoring, and facility costs.
At a doctor-led clinic like The Wellness London, the additional cost over pharmacy pricing reflects genuine clinical value — a full medical consultation with a GMC-registered physician who can assess your medical history, identify contraindications, advise on the appropriate dosing schedule, and manage any adverse reactions with the authority to prescribe if needed.
When viewed against the potential consequences of meningococcal disease — a case fatality rate of 8–15%, and up to 20% of survivors left with permanent disabilities including brain damage, hearing loss, and limb amputations — the cost of vaccination represents a proportionate and defensible investment.
Who Needs the Meningitis B Vaccine the Most
While the vaccine is suitable for anyone aged two months and above who has not previously been vaccinated, certain groups face the highest risk and should prioritise vaccination.
University students represent one of the most important groups for MenB vaccination. The 2026 Kent outbreak has demonstrated precisely why. Students mix closely with large numbers of new people, live in shared halls of residence, socialise in crowded indoor venues, and are more likely to share drinks and vapes. Between 10% and 25% of teenagers carry meningococcal bacteria in their throats without symptoms, and the bacteria can be passed to others through these close-contact behaviours. Virtually all current UK university students were born before the NHS MenB programme began in 2015 and are unvaccinated.
Teenagers aged 14–18 face similar risks, particularly those preparing to attend university. Vaccinating before entry into higher education provides protection during the highest-risk period.
Parents of children born before May 2015 should be aware that their children will not have been offered MenB vaccination through the NHS. If your child is now a teenager or young adult, they remain unprotected unless vaccinated privately.
Travellers heading to regions with higher meningococcal disease rates — particularly sub-Saharan Africa — may need MenB vaccination alongside the MenACWY vaccine.
Healthcare workers in clinical settings where they may encounter meningococcal patients should ensure they are vaccinated.
Young adults in shared accommodation — including house-shares, military barracks, and other communal living environments — face elevated risk due to the close-contact nature of their living arrangements.
Get Protected — Contact The Wellness London →
The Meningitis B Vaccine: How It Works and What to Expect
The vaccine used in the UK is Bexsero, manufactured by GSK. It is a non-live recombinant vaccine — it contains laboratory-produced proteins from the surface of meningococcal B bacteria, not living bacteria, so it cannot cause meningitis.
Bexsero protects against approximately 88% of MenB strains circulating in the UK (Meningitis Now, 2026). While no vaccine offers 100% protection, the UK childhood immunisation programme demonstrated a 75% reduction in invasive MenB disease among vaccinated infants over a three-year period following the programme's introduction (European Medicines Agency, 2025).
Dosing schedule for adults and adolescents (11 years and over): Two doses are required, given at least one month apart. The optimal schedule for maximum long-term protection is doses at 0 and 6 months. If you need protection more quickly — for example, because a university term is approaching — a three-dose schedule at 0, 1–2, and 6 months provides faster immunity. Some protection begins after the first dose, but the full course is necessary for robust protection.
Children aged 2–10 years: Require two doses, given at least two months apart.
Infants under 2 years: Follow the NHS schedule of three doses plus a booster, or a catch-up schedule as advised by your doctor.
Side effects are common but overwhelmingly mild and short-lived. The most frequently reported reactions include pain, redness, or swelling at the injection site (reported in 87–92% of clinical trial participants), fatigue (45–49%), headache (37–41%), nausea (11–13%), and muscle pain (10–14%). These typically resolve within 24–48 hours. Serious adverse reactions are very rare — after more than five million doses administered in the UK, no major safety concerns have been identified.
The National Vaccine Shortage: What It Means for You
The March 2026 Kent meningitis outbreak has triggered a surge in demand for private MenB vaccination that has overwhelmed supply chains across the UK. Understanding the current situation will help you navigate your options.
On 18 March 2026, the chairman of the National Pharmacy Association confirmed on BBC Radio 4 that there is "no stock" of MenB vaccines available through most wholesale distributors for private purchase, with "no date of resupply." A survey of 300 pharmacies found that 87% have experienced "considerable" increases in requests for the vaccine, far exceeding available supply. Boots has implemented a queuing system for its website, and Superdrug has created a waiting list.
The Health Secretary has stated that NHS stocks for the targeted University of Kent programme are "sufficient," but this is a separate supply channel from the private market. Private clinics and pharmacies source their vaccines through pharmaceutical wholesalers, and this supply has been largely exhausted.
What this means in practice: If you want to be vaccinated privately, you should contact providers as soon as possible. Do not assume that your preferred provider has stock — check availability before booking. Be prepared that you may need to register your interest and wait for supply to be replenished.
At The Wellness London, we are actively working with our suppliers to maintain vaccine availability. We cannot guarantee stock at all times during this unprecedented period, but we are doing everything we can to serve our patients. Contact us to check current availability and, if we are temporarily out of stock, to register on our priority list.
Or email team@thewellnesslondon.com to register your interest.
Pharmacy vs Doctor-Led Vaccination: Which Should You Choose
This is a question many people are asking, particularly as pharmacy stock has become unavailable and patients look to private clinics as an alternative. Here is a transparent comparison to help you decide.
Pharmacy vaccination (Boots, Superdrug, Well, independents) typically costs £100–120 per dose, with the vaccine administered by a qualified pharmacist after a brief screening questionnaire. The process is quick and convenient, usually completed in about 15 minutes. For healthy adults with no complex medical history, this is a perfectly appropriate and cost-effective option — when stock is available.
Doctor-led vaccination at a clinic like The Wellness London costs more (from £195 per dose) but provides a fundamentally different level of service. A GMC-registered doctor conducts a thorough medical history review, assesses whether you have any contraindications or conditions that might affect vaccine suitability (such as immunosuppression, pregnancy, complement disorders, or previous allergic reactions), discusses the optimal dosing schedule for your individual circumstances, and remains available to manage any adverse reactions. The appointment is conducted in a calm, private clinical environment rather than a busy pharmacy.
For people with complex medical histories, those on immunosuppressive medication, pregnant or breastfeeding women, or anyone who simply wants the reassurance of a doctor-led service, the premium is justified. For healthy young adults with no complications, either option is clinically appropriate — but availability is currently the decisive factor for most people.
Frequently Asked Questions
How much does the meningitis B vaccine cost in the UK?
Privately, the MenB vaccine typically costs £100–195 per dose depending on the provider, with the full two-dose course ranging from £200 to £390. Pharmacies are the most affordable (£100–120/dose), while doctor-led clinics charge £150–195/dose. At The Wellness London, vaccination starts from £195/dose.
Can I get the meningitis B vaccine free on the NHS?
Only for infants (born since 2015) and individuals with specific high-risk medical conditions. Most adults, teenagers, and students must pay privately. The JCVI has been asked to re-examine broader eligibility following the Kent outbreak, but no expansion has been announced.
Is the meningitis B vaccine worth the money?
Meningococcal B disease has a case fatality rate of 8–15% and can kill within 24 hours. Up to 20% of survivors suffer permanent disabilities. Bexsero protects against ~88% of UK MenB strains. At £200–390 for a full course, this is a significant but proportionate investment against a devastating illness.
Why is the vaccine more expensive at a private clinic?
The additional cost reflects a full consultation with a GMC-registered doctor, comprehensive medical assessment, personalised clinical advice, and post-vaccination monitoring in a private clinical environment — rather than a brief pharmacist-administered service.
How many doses do I need as an adult?
Two doses of Bexsero, given at least one month apart (optimally at 0 and 6 months). An accelerated three-dose schedule is available for those needing faster protection.
Is there a meningitis B vaccine shortage?
Yes. Following the March 2026 Kent outbreak, the National Pharmacy Association confirmed there is "no stock" available across most private wholesale distributors. Many pharmacies have suspended bookings. Contact The Wellness London on WhatsApp (+44 7961 280835) to check our current availability.
Can I get vaccinated if I am over 25?
Bexsero is licensed in the UK for use from two months of age with no upper age limit. While the highest risk is in young adults aged 16–25, the vaccine can be administered to adults of any age. Discuss your individual risk profile with your doctor.
The Wellness London is a private healthcare group providing doctor-led medical services from our Marylebone clinic. All vaccinations are administered by GMC-registered doctors. For meningitis B vaccine enquiries, contact us on WhatsApp at +44 7961 280835 or email team@thewellnesslondon.com.
This article is for informational purposes only and does not constitute medical advice. If you suspect meningitis symptoms, call 999 or go to your nearest A&E immediately.
References
UK Health Security Agency. Cases of invasive meningococcal disease notified in Kent. GOV.UK. Updated 18 March 2026.
European Medicines Agency. Bexsero — European Public Assessment Report. Updated 2025.
Meningitis Now. FAQs on the MenB vaccine (Bexsero). Updated 2026.
GSK. Bexsero Summary of Product Characteristics. Electronic Medicines Compendium. 2025.
CDC/ACIP. New dosing interval and schedule for Bexsero MenB-4C vaccine. MMWR. December 2024.
National Pharmacy Association. Vaccine supply update. 18 March 2026.
Streeting W. Secretary of State update to the House on meningitis outbreak. GOV.UK. 17 March 2026.
